Neonc Technologies Holdings (NTHI) Profit After Tax (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Profit After Tax of -$8.8 million for Q1 2026, up 72.72% year-over-year from -$5.1 million in Q1 2025, and up 43.19% quarter-over-quarter from -$15.5 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Profit After Tax (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Profit After Tax for 3 consecutive years, with -$8.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax rose 72.72% year-over-year to -$8.8 million; the TTM figure through Mar 2026 stood at -$38.6 million (up 6.41% YoY), while the FY2025 annual figure was -$62.1 million, down 422.3% from the prior year.
- Profit After Tax grew to -$8.8 million in Q1 2026 per NTHI's latest filing, from -$15.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$2.2 million in Q3 2024 and bottomed at -$32.3 million in Q1 2025.
- Historically, Profit After Tax has averaged -$9.2 million across 3 years, with a median of -$5.7 million in 2025.
- Annual changes were most pronounced in 2025 — Profit After Tax tumbled 999.91% — and 2026, when it surged 72.72%.
- Neonc Technologies Holdings' Profit After Tax stood at -$2.3 million in 2024, then slumped by 589.05% to -$15.5 million in 2025, then surged by 43.19% to -$8.8 million in 2026.
- Business Quant data shows NTHI's Profit After Tax at -$8.8 million in Q1 2026, -$15.5 million in Q4 2025, and -$8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -14.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.24 Mn |
| Mar 31, 2026 | -8.82 Mn |
| Dec 31, 2025 | -15.52 Mn |
| Sep 30, 2025 | -8.62 Mn |
| Jun 30, 2025 | -5.68 Mn |
| Mar 31, 2025 | -32.33 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -4.52 Mn |
| Mar 31, 2024 | -2.94 Mn |